Cargando…

1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series

Detalles Bibliográficos
Autores principales: Lim, K.H.J., Punie, K., Oing, C., Thorne, E., Murali, K., Kamposioras, K.V., O'Connor, M., Elez, E., Amaral, T.M.S., Lopez, P. Garrido, Lambertini, M., Devnani, B., Westphalen, C.B., Morgan, G., Haanen, J.B.A.G., Hardy, C., Banerjee, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454455/
http://dx.doi.org/10.1016/j.annonc.2021.08.1554
_version_ 1784570494931959808
author Lim, K.H.J.
Punie, K.
Oing, C.
Thorne, E.
Murali, K.
Kamposioras, K.V.
O'Connor, M.
Elez, E.
Amaral, T.M.S.
Lopez, P. Garrido
Lambertini, M.
Devnani, B.
Westphalen, C.B.
Morgan, G.
Haanen, J.B.A.G.
Hardy, C.
Banerjee, S.
author_facet Lim, K.H.J.
Punie, K.
Oing, C.
Thorne, E.
Murali, K.
Kamposioras, K.V.
O'Connor, M.
Elez, E.
Amaral, T.M.S.
Lopez, P. Garrido
Lambertini, M.
Devnani, B.
Westphalen, C.B.
Morgan, G.
Haanen, J.B.A.G.
Hardy, C.
Banerjee, S.
author_sort Lim, K.H.J.
collection PubMed
description
format Online
Article
Text
id pubmed-8454455
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Society for Medical Oncology. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-84544552021-09-21 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series Lim, K.H.J. Punie, K. Oing, C. Thorne, E. Murali, K. Kamposioras, K.V. O'Connor, M. Elez, E. Amaral, T.M.S. Lopez, P. Garrido Lambertini, M. Devnani, B. Westphalen, C.B. Morgan, G. Haanen, J.B.A.G. Hardy, C. Banerjee, S. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454455/ http://dx.doi.org/10.1016/j.annonc.2021.08.1554 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Lim, K.H.J.
Punie, K.
Oing, C.
Thorne, E.
Murali, K.
Kamposioras, K.V.
O'Connor, M.
Elez, E.
Amaral, T.M.S.
Lopez, P. Garrido
Lambertini, M.
Devnani, B.
Westphalen, C.B.
Morgan, G.
Haanen, J.B.A.G.
Hardy, C.
Banerjee, S.
1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
title 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
title_full 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
title_fullStr 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
title_full_unstemmed 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
title_short 1561O The future of the oncology workforce since COVID-19: Results of the ESMO Resilience Task Force survey series
title_sort 1561o the future of the oncology workforce since covid-19: results of the esmo resilience task force survey series
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454455/
http://dx.doi.org/10.1016/j.annonc.2021.08.1554
work_keys_str_mv AT limkhj 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT puniek 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT oingc 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT thornee 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT muralik 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT kamposioraskv 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT oconnorm 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT eleze 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT amaraltms 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT lopezpgarrido 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT lambertinim 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT devnanib 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT westphalencb 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT morgang 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT haanenjbag 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT hardyc 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries
AT banerjees 1561othefutureoftheoncologyworkforcesincecovid19resultsoftheesmoresiliencetaskforcesurveyseries